Tedavi Planlama
Aktif Tedavi Planları
67
12%Başarı Oranı
94.2%
3.1%İlaç Etkileşimleri
8
5%Reçete Edilen İlaçlar
324
8.5%Örnek Tedavi Planı
İlaç Tedavisi
-
High Priority
Amoxicillin-Clavulanate 875mg/125mg
PO BID x 7 days | Priority: STAT
-
Routine
Azithromycin 500mg
PO daily x 5 days | Priority: Routine
-
PRN
Acetaminophen 500mg
PO Q6H PRN fever/pain | Max 3g/day
İlaç Etkileşimi Uyarısı
No significant interactions detected for current medication regimen.
İlaç Dışı Müdahaleler
-
Oxygen Therapy
Maintain SpO2 >92% via nasal cannula 2-4L/min
-
Respiratory Physiotherapy
Incentive spirometry Q2H while awake
-
Hydration
Encourage PO fluids 2-3L/day or IV NS at 100mL/hr
İzleme Planı
- Vital signs Q4H (BP, HR, RR, Temp, SpO2)
- Daily chest auscultation for crackles/wheezing
- CBC, CMP on Day 3 to assess response
- Chest X-ray follow-up in 48-72 hours
- Monitor for adverse drug reactions (rash, GI upset)
Tedavi Hedefleri
- Resolution of fever within 48-72 hours
- Improvement in respiratory symptoms (cough, dyspnea)
- SpO2 >95% on room air by Day 5
- Clear chest X-ray by Week 2-3
- Return to baseline functional status
Son Tedavi Planları
| Hasta ID | Tanı | İlaçlar | Durum | Tarih | İşlemler |
|---|---|---|---|---|---|
| P-1023 | Pneumonia (J18.9) | Amoxicillin-Clav, Azithromycin | Active | 2024-01-15 14:30 | |
| P-0987 | STEMI (I21.9) | Aspirin, Clopidogrel, Atorvastatin | Critical | 2024-01-15 13:15 | |
| P-0892 | Ischemic Stroke (I63.9) | Alteplase, Aspirin | Active | 2024-01-15 12:00 |